mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0051 |
0.9 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
mRNA |
BRD-A02303741 |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
mRNA |
Mdivi-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0048 |
0.9 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
0.0048 |
0.9 |
mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
0.9 |
mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.0062 |
0.9 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
-0.0081 |
0.9 |